License and Collaboration Agreements - Pfizer (Details) - Asset Contribution Agreement - Pfizer - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||
| Milestone payments | $ 0 | $ 0 |
| Royalties payments | $ 0 | $ 0 |
| X | ||||||||||
- Definition Milestone payments. No definition available.
|
| X | ||||||||||
- Definition The amount of cash paid for royalties during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|